Drawing for UNIVERSAL PATIENT LANGUAGE

USPTO serial 90094344

UNIVERSAL PATIENT LANGUAGE

Reviewed by CopyMark Law Group

Reg. 6708116Status 700Registered
Filing date
Status date
Registration date
Apr 19, 2022
Examiner
COLLIER, DAVID E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UNIVERSAL PATIENT LANGUAGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb CompanyP.O. Box 4000Trademark Dept., Mailstop D4243Princeton, NJ 08648-4000

Goods and services

ClassDescriptionStatusFirst use
044Providing healthcare information to healthcare professionals regarding better methods for communicating with patients regarding their healthcareACTIVEApr 20, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 2, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 2, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 2, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 19, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 18, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 17, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 24, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 24, 2022EX1GSOU EXTENSION 1 GRANTED—
Feb 24, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 17, 2022IUAFUSE AMENDMENT FILED—
Feb 17, 2022EXT1SOU EXTENSION 1 FILED—
Feb 17, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 17, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 22, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 22, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 2, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 19, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 18, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2020DOCKASSIGNED TO EXAMINER—
Sep 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance